AAV Immunogenicity: New Answers Create New Questions

Files
main-3.pdf (243.2 KB)
If you need an accessible version of this item, please submit a remediation request.
Date
2018-11-07
Authors
Shirley, Jamie L.
Herzog, Roland W.
Language
American English
Embargo Lift Date
Department
Pediatrics, School of Medicine
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Elsevier
Abstract

Comment on

Exposure to wild-type AAV drives distinct capsid immunity profiles in humans. [J Clin Invest. 2018]
Description
Keywords
Capsid, Capsid proteins, Dependovirus, Humans
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Shirley, J. L., & Herzog, R. W. (2018). AAV Immunogenicity: New Answers Create New Questions. Molecular therapy : the journal of the American Society of Gene Therapy, 26(11), 2538–2539. doi:10.1016/j.ymthe.2018.10.004
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Molecular Therapy
Rights
Publisher Policy
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
https://hdl.handle.net/1805/21726
DOI
https://doi.org/10.1016/j.ymthe.2018.10.004
Version
Full Text Available at
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225012/
This item is under embargo {{howLong}}
Collections
Open Access Policy Articles
Department of Pediatrics Works